Wai Yuen Tong Medicine Holdings Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Ching Ho Tang
Chief executive officer
HK$15.5m
Total compensation
| CEO salary percentage | 94.1% |
| CEO tenure | 6.1yrs |
| CEO ownership | n/a |
| Management average tenure | 3yrs |
| Board average tenure | 6.1yrs |
Recent management updates
Recent updates
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding
Mar 11
The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business
Dec 28Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?
Jul 11Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt
Jul 05Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?
Mar 08Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now
Aug 18Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?
Mar 17Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares
Jan 22Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?
Dec 16
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | HK$36m |
| Jun 30 2023 | n/a | n/a | HK$8m |
| Mar 31 2023 | HK$16m | HK$15m | -HK$21m |
| Dec 31 2022 | n/a | n/a | -HK$98m |
| Sep 30 2022 | n/a | n/a | -HK$176m |
| Jun 30 2022 | n/a | n/a | -HK$143m |
| Mar 31 2022 | HK$9m | HK$8m | -HK$109m |
| Dec 31 2021 | n/a | n/a | -HK$122m |
| Sep 30 2021 | n/a | n/a | -HK$135m |
| Jun 30 2021 | n/a | n/a | -HK$255m |
| Mar 31 2021 | HK$8m | HK$8m | -HK$376m |
| Dec 31 2020 | n/a | n/a | -HK$98m |
| Sep 30 2020 | n/a | n/a | HK$179m |
| Jun 30 2020 | n/a | n/a | HK$309m |
| Mar 31 2020 | HK$15m | HK$12m | HK$439m |
| Dec 31 2019 | n/a | n/a | HK$253m |
| Sep 30 2019 | n/a | n/a | HK$66m |
| Jun 30 2019 | n/a | n/a | HK$71m |
| Mar 31 2019 | HK$14m | HK$12m | HK$75m |
| Dec 31 2018 | n/a | n/a | HK$20m |
| Sep 30 2018 | n/a | n/a | -HK$35m |
| Jun 30 2018 | n/a | n/a | -HK$75m |
| Mar 31 2018 | HK$13m | HK$12m | -HK$116m |
Compensation vs Market: Ching Ho's total compensation ($USD1.99M) is above average for companies of similar size in the Hong Kong market ($USD233.89K).
Compensation vs Earnings: Ching Ho's compensation has been consistent with company performance over the past year.
CEO
Ching Ho Tang (61 yo)
6.1yrs
Tenure
HK$15,541,000
Compensation
Mr. Ching Ho Tang, GBS, SBS, JP is Chairman of China Agri-Products Exchange Limited since February 8, 2021 and re-designated as its Executive Director since October 01, 2022. Mr. Tang Co-founded Wang On Gr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & MD | 6.1yrs | HK$15.54m | no data | |
| Executive Director | 6.1yrs | HK$1.90m | no data | |
| Assistant GM of Purchasing Processing & Executive Director | 3.3yrs | HK$678.00k | no data | |
| Financial Controller | 2.3yrs | no data | no data | |
| Head of Factory Operations | 2.7yrs | no data | no data | |
| Company Secretary | less than a year | no data | no data |
3.0yrs
Average Tenure
54yo
Average Age
Experienced Management: 897's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & MD | 22.8yrs | HK$15.54m | no data | |
| Executive Director | 6.1yrs | HK$1.90m | no data | |
| Assistant GM of Purchasing Processing & Executive Director | 3.3yrs | HK$678.00k | no data | |
| Independent Non-Executive Director | 9.2yrs | HK$204.00k | no data | |
| Independent Non-Executive Director | 22.8yrs | HK$184.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
6.1yrs
Average Tenure
60yo
Average Age
Experienced Board: 897's board of directors are considered experienced (6.1 years average tenure).